PT2444399E - Derivados de oxadiazole e sua utilização como potenciadores do receptor de glutamato metabotrópico - 842 - Google Patents

Derivados de oxadiazole e sua utilização como potenciadores do receptor de glutamato metabotrópico - 842 Download PDF

Info

Publication number: PT2444399E
Authority: PT; Portugal
Prior art keywords: potentiators; glutamate receptor; metabotropic glutamate; oxadiazole derivatives; oxadiazole
Prior art date: 2007-06-07

Application number

PT11195016T

Other languages

English (en)

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-06-07

Filing date

2008-06-05

Publication date

2015-03-04

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40093925&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT2444399(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-06-05 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2015-03-04 Publication of PT2444399E publication Critical patent/PT2444399E/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Physical Education & Sports Medicine (AREA)
Addiction (AREA)
Heart & Thoracic Surgery (AREA)
Psychology (AREA)
Diabetes (AREA)
Cardiology (AREA)
Urology & Nephrology (AREA)
Orthopedic Medicine & Surgery (AREA)
Ophthalmology & Optometry (AREA)
Hospice & Palliative Care (AREA)
Anesthesiology (AREA)
Hematology (AREA)
Rheumatology (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Epidemiology (AREA)

PT11195016T 2007-06-07 2008-06-05 Derivados de oxadiazole e sua utilização como potenciadores do receptor de glutamato metabotrópico - 842 PT2444399E (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US94255307P	2007-06-07	2007-06-07

Publications (1)

Publication Number	Publication Date
PT2444399E true PT2444399E (pt)	2015-03-04

Family

ID=40093925

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PT11195016T PT2444399E (pt)	2007-06-07	2008-06-05	Derivados de oxadiazole e sua utilização como potenciadores do receptor de glutamato metabotrópico - 842
PT08779348T PT2167502E (pt)	2007-06-07	2008-06-05	Derivados de oxadiazole e sua utilização como potenciadores do receptor de glutamato metabotrópico - 842

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
PT08779348T PT2167502E (pt)	2007-06-07	2008-06-05	Derivados de oxadiazole e sua utilização como potenciadores do receptor de glutamato metabotrópico - 842

Country Status (34)

Country	Link
US (2)	US8377940B2 (pt)
EP (2)	EP2167502B3 (pt)
JP (2)	JP5416696B2 (pt)
KR (2)	KR20100017640A (pt)
CN (2)	CN101679403B (pt)
AR (1)	AR066882A1 (pt)
AU (1)	AU2008260717B2 (pt)
BR (1)	BRPI0812889A2 (pt)
CA (1)	CA2690856C (pt)
CL (1)	CL2008001667A1 (pt)
CO (1)	CO6251287A2 (pt)
CY (2)	CY1113422T1 (pt)
DK (2)	DK2167502T3 (pt)
EC (1)	ECSP109856A (pt)
ES (2)	ES2393425T7 (pt)
HK (2)	HK1166978A1 (pt)
HR (2)	HRP20120909T4 (pt)
IL (1)	IL202158A (pt)
ME (1)	ME01488B (pt)
MX (1)	MX2009013078A (pt)
MY (1)	MY158066A (pt)
NZ (1)	NZ582445A (pt)
PE (1)	PE20090328A1 (pt)
PL (2)	PL2167502T6 (pt)
PT (2)	PT2444399E (pt)
RS (2)	RS53845B1 (pt)
RU (2)	RU2470931C2 (pt)
SA (1)	SA08290344B1 (pt)
SI (2)	SI2167502T1 (pt)
TW (1)	TWI417100B (pt)
UA (1)	UA99129C2 (pt)
UY (1)	UY31124A1 (pt)
WO (1)	WO2008150233A1 (pt)
ZA (1)	ZA200908285B (pt)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7868008B2 (en) *	2005-08-12	2011-01-11	Astrazeneca Ab	Substituted isoindolones and their use as metabotropic glutamate receptor potentiators
US7807706B2 (en) *	2005-08-12	2010-10-05	Astrazeneca Ab	Metabotropic glutamate-receptor-potentiating isoindolones
TW200804281A (en) *	2006-02-16	2008-01-16	Astrazeneca Ab	New metabotropic glutamate receptor-potentiating isoindolones
AR059898A1 (es)	2006-03-15	2008-05-07	Janssen Pharmaceutica Nv	Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
TW200900065A (en)	2007-03-07	2009-01-01	Janssen Pharmaceutica Nv	3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
TW200845978A (en)	2007-03-07	2008-12-01	Janssen Pharmaceutica Nv	3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
TW200911255A (en)	2007-06-07	2009-03-16	Astrazeneca Ab	Metabotropic glutamate receptor oxadiazole ligands and their use as potentiators-841
TWI417100B (zh)	2007-06-07	2013-12-01	Astrazeneca Ab	二唑衍生物及其作為代謝型麩胺酸受體增效劑-８４２之用途
EA016969B1 (ru)	2007-09-14	2012-08-30	Аддекс Фарма С.А.	1,3-двузамещенные-4-фенил-1н-пиридин-2-оны
CA2697399C (en)	2007-09-14	2016-01-19	Ortho-Mcneil-Janssen Pharmaceuticals, Inc.	1,3-disubstituted 4-(aryl-x-phenyl)-1h-pyridin-2-ones
SI2203439T1 (sl)	2007-09-14	2011-05-31	Ortho Mcneil Janssen Pharm	1',3'-disubstituirani 4-fenil-3,4,5,6-tetrahidro-2H-1'H-(1,4')bipiridinil-2'-oni
JP5433582B2 (ja) *	2007-11-14	2014-03-05	ジャンセンファーマシューティカルズ，インコーポレイテッド．	イミダゾ［１，２−ａ］ピリジン誘導体およびｍＧｌｕＲ２受容体の正のアロステリック調節因子としてのその使用
SA109300358B1 (ar) *	2008-06-06	2012-11-03	استرازينيكا ايه بي	مقويات مستقبل جلوتامات ذي انتحاء أيضي من أيزو إندولون
AU2009260905B2 (en)	2008-06-20	2012-08-23	Astrazeneca Ab	Dibenzothiazepine derivatives and use thereof
RU2510396C2 (ru)	2008-09-02	2014-03-27	Янссен Фармасьютикалз, Инк.	3-азабицикло[3.1.0]гексильные производные в качестве модуляторов метаботропных глутаматных рецепторов
BRPI0920354A2 (pt)	2008-10-16	2017-06-27	Addex Pharmaceuticals Sa	derivados de indol e benzomorfolina como moduladores de receptores de glutamato metabotrópicos
JP5690277B2 (ja)	2008-11-28	2015-03-25	ジャンセンファーマシューティカルズ，インコーポレイテッド．	代謝型グルタミン酸受容体の調節因子としてのインドールおよびベンゾオキサジン誘導体
WO2010130424A1 (en)	2009-05-12	2010-11-18	Ortho-Mcneil-Janssen Pharmaceuticals, Inc	1,2,3-triazolo [4,3-a] pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders
MY153913A (en)	2009-05-12	2015-04-15	Janssen Pharmaceuticals Inc	7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
BRPI1010831A2 (pt)	2009-05-12	2016-04-05	Addex Pharmaceuticals Sa	derivados de 1,2,4-triazolo[4,3-a]piridina e seu como moduladores alostéricos positivos de receptores de mglur2
SG181958A1 (en) *	2010-01-07	2012-07-30	Astrazeneca Ab	Process for making a metabotropic glutamate receptor positive allosteric modulator - 874
AU2011245737A1 (en) *	2010-04-30	2012-12-20	Astrazeneca Ab	Polymorphs of a metabotropic glutamate receptor positive allosteric modulator
AU2011328194B2 (en)	2010-11-08	2015-04-16	Janssen Pharmaceuticals, Inc.	1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
ES2536433T3 (es)	2010-11-08	2015-05-25	Janssen Pharmaceuticals, Inc.	Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2
US8993591B2 (en)	2010-11-08	2015-03-31	Janssen Pharmaceuticals, Inc.	1,2,4-triazolo[4,3-a] pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors
CN102180872B (zh) *	2011-04-01	2014-04-02	华中科技大学	[1,3,4]噁二唑类衍生物及其应用
JO3368B1 (ar)	2013-06-04	2019-03-13	Janssen Pharmaceutica Nv	مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar)	2013-09-06	2019-03-13	Janssen Pharmaceutica Nv	مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
UA128346C2 (uk)	2014-01-21	2024-06-19	Янссен Фармацевтика Нв	Комбінації, які містять позитивні алостеричні модулятори або ортостеричні агоністи метаботропного глутаматергічного рецептора 2 підтипу, та їх застосування
ES2748633T3 (es)	2014-01-21	2020-03-17	Janssen Pharmaceutica Nv	Combinaciones que comprenden moduladores alostéricos positivos del receptor glutamatérgico metabotrópico de subtipo 2 y su uso
WO2017014170A1 (ja) *	2015-07-17	2017-01-26	武田薬品工業株式会社	複素環化合物
AU2016297362B2 (en)	2015-07-17	2020-04-16	Takeda Pharmaceutical Company Limited	Oxadiazole derivatives useful as HDAC inhibitors
WO2017033946A1 (ja)	2015-08-25	2017-03-02	武田薬品工業株式会社	複素環化合物
WO2020102216A1 (en)	2018-11-13	2020-05-22	Incyte Corporation	Substituted heterocyclic derivatives as pi3k inhibitors
US11161838B2 (en)	2018-11-13	2021-11-02	Incyte Corporation	Heterocyclic derivatives as PI3K inhibitors
US11078204B2 (en)	2018-11-13	2021-08-03	Incyte Corporation	Heterocyclic derivatives as PI3K inhibitors
AU2020312742A1 (en) *	2019-07-18	2022-02-17	Abaxys Therapeutics	Solid formulation of a 1,2,4-oxadiazole derivative
GB2621323A (en)	2022-08-03	2024-02-14	Sirgartan Holdings Ltd	Treatments for obsessive compulsive disorder

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2008803A (en) *	1932-04-18	1935-07-23	Stephan Engineering Corp	Fuel atomizing and igniting means
US3993617A (en) *	1975-10-30	1976-11-23	Morton-Norwich Products, Inc.	Antifungal 2-substituted phthalimidines
US5175157A (en) *	1985-11-27	1992-12-29	Boehringer Ingelheim Gmbh	Cyclic amine derivatives, pharmaceutical compositions containing these compounds and methods for preparing them
WO1992017448A1 (en)	1991-04-01	1992-10-15	Kyowa Hakko Kogyo Co., Ltd.	3-methyleneisoindolin-1-one derivative
TW219935B (pt)	1991-12-25	1994-02-01	Mitsubishi Chemicals Co Ltd
EP0602814A1 (en)	1992-12-18	1994-06-22	Takeda Chemical Industries, Ltd.	Crystal forms of optically active isoindolines and their use
US5681954A (en) *	1993-05-14	1997-10-28	Daiichi Pharmaceutical Co., Ltd.	Piperazine derivatives
RU2124511C1 (ru) *	1993-05-14	1999-01-10	Фармасьютикал Ко., Лтд	Производные пиперазина
EP0887340A4 (en) *	1996-02-06	2000-03-29	Japan Tobacco Inc	CHEMICAL COMPOUNDS AND THEIR PHARMACEUTICAL USE
EP0999208A4 (en)	1997-05-30	2001-08-08	Meiji Seika Kaisha	NITROGEN-BASED HETEROCYCLIC COMPOUNDS AND MEDICINES FOR TREATING HYPERLIPEMIA THAT CONTAIN THEM
IL136250A0 (en)	1997-11-21	2001-05-20	Nps Pharma Inc	Metabotropic glutamate receptor antagonist compounds
RU2257384C2 (ru) *	2000-02-29	2005-07-27	Мицубиси Фарма Корпорейшн	Новые производные циклического амида
EA200300064A1 (ru)	2000-07-31	2003-06-26	Смитклайн Бичем Пи-Эл-Си	Карбоксамидные соединения и их применение в качестве антагонистов 11cby-рецептора человека
PL368109A1 (en) *	2001-04-19	2005-03-21		2-iminopyrrolidine derivates
KR20040022238A (ko)	2001-08-09	2004-03-11	오노 야꾸힝 고교 가부시키가이샤	카르복실산 유도체 화합물 및 그 화합물을 유효성분으로서 함유하는 약제
AU2003226927A1 (en)	2002-04-09	2003-10-27	7Tm Pharma A/S	Novel carboxamide compounds for use in mch receptor related disorders
FR2840302B1 (fr)	2002-06-03	2004-07-16	Aventis Pharma Sa	Derives d'isoindolones, procede de preparation et intermediaire de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
DE10238865A1 (de)	2002-08-24	2004-03-11	Boehringer Ingelheim International Gmbh	Neue Carbonsäureamid-Verbindungen mit MCH-antagonistischer Wirkung, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
GB0223232D0 (en)	2002-10-07	2002-11-13	Pfizer Ltd	Chemical compounds
AR042139A1 (es) *	2002-11-26	2005-06-08	Maruishi Pharma	Derivados de isoindolina, composicion farmaceutica que los contiene, y uso
AU2004226450A1 (en)	2003-03-26	2004-10-14	Merck & Co. Inc.	Benzamide modulators of metabotropic glutamate receptors
GB0308025D0 (en)	2003-04-07	2003-05-14	Glaxo Group Ltd	Compounds
US7129260B2 (en) *	2003-06-02	2006-10-31	Abbott Laboratories	Isoindolinone kinase inhibitors
WO2005040157A2 (en)	2003-10-22	2005-05-06	Eli Lilly And Company	Novel mch receptor antagonists
JP2007519754A (ja)	2004-01-30	2007-07-19	スミスクラインビーチャムコーポレーション	化合物
DE602005008558D1 (de) *	2004-02-18	2008-09-11	Astrazeneca Ab	Kondensierte heterocyclische verbindungen und deren verwendung als antagonisten des metabotropen reznkungen
EP1726585A4 (en)	2004-03-05	2009-07-15	Banyu Pharma Co Ltd	HETEROCYCLIC DERIVATIVE WITH FIVE ELEMENTS SUBSTITUTED BY A DIARYLE
CA2558848C (en)	2004-03-05	2013-11-19	Nissan Chemical Industries, Ltd.	Isoxazoline-substituted benzamide compound and pesticide
SE0400970D0 (sv)	2004-04-14	2004-04-14	Astrazeneca Ab	Nicotinic acetylcholine receptor ligands
TW200613272A (en) *	2004-08-13	2006-05-01	Astrazeneca Ab	Isoindolone compounds and their use as metabotropic glutamate receptor potentiators
AU2005299797A1 (en)	2004-10-25	2006-05-04	Merck & Co., Inc.	Heterocyclic indanone potentiators of metabotropic glutamate receptors
CA2598531A1 (en)	2005-02-24	2006-08-31	Merck & Co., Inc.	Benzazole potentiators of metabotropic glutamate receptors
GB0510142D0 (en) *	2005-05-18	2005-06-22	Addex Pharmaceuticals Sa	Novel compounds A1
BRPI0611423A2 (pt) *	2005-05-18	2010-09-08	Addex Pharmaceuticals Sa	derivados de oxadiazol substituìdos como moduladores alostéricos positivos de receptores de glutamato metabotrópicos e seus usos
TW200728277A (en)	2005-06-29	2007-08-01	Palau Pharma Sa	Bicyclic derivatives as P38 inhibitors
EP1912939A1 (en) *	2005-08-12	2008-04-23	AstraZeneca AB	Metabotropic glutamate-receptor-potentiating isoindolones
US7868008B2 (en) *	2005-08-12	2011-01-11	Astrazeneca Ab	Substituted isoindolones and their use as metabotropic glutamate receptor potentiators
US7807706B2 (en) *	2005-08-12	2010-10-05	Astrazeneca Ab	Metabotropic glutamate-receptor-potentiating isoindolones
EP1934214B1 (en) *	2005-09-27	2010-04-07	F.Hoffmann-La Roche Ag	Oxadiazolyl pyrazolo-pyrimidines as mglur2 antagonists
TW200804281A (en) *	2006-02-16	2008-01-16	Astrazeneca Ab	New metabotropic glutamate receptor-potentiating isoindolones
TW200911255A (en) *	2007-06-07	2009-03-16	Astrazeneca Ab	Metabotropic glutamate receptor oxadiazole ligands and their use as potentiators-841
TWI417100B (zh) *	2007-06-07	2013-12-01	Astrazeneca Ab	二唑衍生物及其作為代謝型麩胺酸受體增效劑-８４２之用途

2008
- 2008-06-04 TW TW097120762A patent/TWI417100B/zh not_active IP Right Cessation
- 2008-06-05 JP JP2010511147A patent/JP5416696B2/ja not_active Expired - Fee Related
- 2008-06-05 MY MYPI20095187A patent/MY158066A/en unknown
- 2008-06-05 CN CN2008800191548A patent/CN101679403B/zh not_active Expired - Fee Related
- 2008-06-05 EP EP08779348.5A patent/EP2167502B3/en active Active
- 2008-06-05 NZ NZ582445A patent/NZ582445A/en not_active IP Right Cessation
- 2008-06-05 RS RS20150130A patent/RS53845B1/en unknown
- 2008-06-05 KR KR1020097025404A patent/KR20100017640A/ko active Search and Examination
- 2008-06-05 PT PT11195016T patent/PT2444399E/pt unknown
- 2008-06-05 UA UAA200911794A patent/UA99129C2/ru unknown
- 2008-06-05 WO PCT/SE2008/050666 patent/WO2008150233A1/en active Application Filing
- 2008-06-05 PL PL08779348T patent/PL2167502T6/pl unknown
- 2008-06-05 EP EP11195016.8A patent/EP2444399B1/en active Active
- 2008-06-05 RU RU2009147708/04A patent/RU2470931C2/ru not_active IP Right Cessation
- 2008-06-05 CA CA2690856A patent/CA2690856C/en not_active Expired - Fee Related
- 2008-06-05 MX MX2009013078A patent/MX2009013078A/es active IP Right Grant
- 2008-06-05 PT PT08779348T patent/PT2167502E/pt unknown
- 2008-06-05 SI SI200830807T patent/SI2167502T1/sl unknown
- 2008-06-05 KR KR1020157026785A patent/KR20150116907A/ko not_active Application Discontinuation
- 2008-06-05 AU AU2008260717A patent/AU2008260717B2/en not_active Ceased
- 2008-06-05 RS RS20120507A patent/RS52526B2/sr unknown
- 2008-06-05 PL PL11195016T patent/PL2444399T3/pl unknown
- 2008-06-05 DK DK08779348.5T patent/DK2167502T3/da active
- 2008-06-05 CN CN201210486921.4A patent/CN102977086B/zh not_active Expired - Fee Related
- 2008-06-05 DK DK11195016T patent/DK2444399T3/en active
- 2008-06-05 AR ARP080102401A patent/AR066882A1/es unknown
- 2008-06-05 SI SI200831385T patent/SI2444399T1/sl unknown
- 2008-06-05 ES ES08779348T patent/ES2393425T7/es active Active
- 2008-06-05 ME MEP-2012-131A patent/ME01488B/me unknown
- 2008-06-05 ES ES11195016.8T patent/ES2531443T3/es active Active
- 2008-06-05 US US12/663,371 patent/US8377940B2/en not_active Expired - Fee Related
- 2008-06-05 BR BRPI0812889A patent/BRPI0812889A2/pt not_active IP Right Cessation
- 2008-06-06 UY UY31124A patent/UY31124A1/es not_active Application Discontinuation
- 2008-06-06 US US12/134,553 patent/US8377939B2/en not_active Expired - Fee Related
- 2008-06-06 PE PE2008000965A patent/PE20090328A1/es not_active Application Discontinuation
- 2008-06-06 CL CL2008001667A patent/CL2008001667A1/es unknown
- 2008-06-07 SA SA08290344A patent/SA08290344B1/ar unknown
2009
- 2009-11-16 IL IL202158A patent/IL202158A/en not_active IP Right Cessation
- 2009-11-23 ZA ZA200908285A patent/ZA200908285B/xx unknown
- 2009-12-04 CO CO09139153A patent/CO6251287A2/es not_active Application Discontinuation
2010
- 2010-01-06 EC EC2010009856A patent/ECSP109856A/es unknown
- 2010-09-15 HK HK12106999.4A patent/HK1166978A1/xx not_active IP Right Cessation
- 2010-09-15 HK HK10108742.2A patent/HK1142318A1/xx not_active IP Right Cessation
2012
- 2012-09-25 RU RU2012141706/04A patent/RU2012141706A/ru not_active Application Discontinuation
- 2012-11-13 HR HRP20120909AT patent/HRP20120909T4/hr unknown
- 2012-11-22 CY CY20121101132T patent/CY1113422T1/el unknown
2013
- 2013-11-14 JP JP2013235538A patent/JP5815644B2/ja not_active Expired - Fee Related
2015
- 2015-02-24 HR HRP20150210TT patent/HRP20150210T1/hr unknown
- 2015-02-26 CY CY20151100204T patent/CY1116150T1/el unknown

Also Published As

Publication number	Publication date
IL202158A (en)	2015-11-30
DK2167502T3 (da)	2012-12-03
EP2167502A4 (en)	2011-04-06
SI2444399T1 (sl)	2015-03-31
ES2393425T7 (es)	2013-11-22
ECSP109856A (es)	2010-02-26
EP2444399B1 (en)	2014-11-26
ZA200908285B (en)	2010-08-25
JP5416696B2 (ja)	2014-02-12
TWI417100B (zh)	2013-12-01
IL202158A0 (en)	2010-06-16
EP2444399A1 (en)	2012-04-25
CN101679403B (zh)	2013-01-02
DK2444399T3 (en)	2015-03-02
CL2008001667A1 (es)	2009-03-06
RU2009147708A (ru)	2011-07-20
PL2167502T3 (pl)	2013-01-31
CN102977086A (zh)	2013-03-20
EP2167502A1 (en)	2010-03-31
PT2167502E (pt)	2012-11-26
EP2167502B1 (en)	2012-09-19
ES2531443T3 (es)	2015-03-16
AU2008260717A1 (en)	2008-12-11
PE20090328A1 (es)	2009-04-24
RU2012141706A (ru)	2014-03-27
HK1166978A1 (en)	2012-11-16
JP2010529118A (ja)	2010-08-26
CA2690856C (en)	2015-12-15
KR20100017640A (ko)	2010-02-16
UY31124A1 (es)	2009-01-30
CN102977086B (zh)	2015-04-01
RS52526B (en)	2013-04-30
US20100267740A1 (en)	2010-10-21
RS52526B2 (sr)	2018-06-29
SA08290344B1 (ar)	2011-10-03
CY1116150T1 (el)	2017-02-08
PL2167502T6 (pl)	2013-12-31
PL2444399T3 (pl)	2015-04-30
JP2014055164A (ja)	2014-03-27
EP2167502B3 (en)	2013-07-10
US8377940B2 (en)	2013-02-19
ME01488B (me)	2014-04-20
WO2008150233A1 (en)	2008-12-11
ES2393425T3 (es)	2012-12-21
CO6251287A2 (es)	2011-02-21
CA2690856A1 (en)	2008-12-11
HRP20150210T1 (en)	2015-06-05
HK1142318A1 (en)	2010-12-03
NZ582445A (en)	2012-03-30
MY158066A (en)	2016-08-30
KR20150116907A (ko)	2015-10-16
US8377939B2 (en)	2013-02-19
JP5815644B2 (ja)	2015-11-17
AU2008260717B2 (en)	2012-01-19
CN101679403A (zh)	2010-03-24
BRPI0812889A2 (pt)	2017-05-23
SI2167502T1 (sl)	2012-12-31
CY1113422T1 (el)	2016-06-22
MX2009013078A (es)	2010-01-15
UA99129C2 (ru)	2012-07-25
AR066882A1 (es)	2009-09-16
RS53845B1 (en)	2015-08-31
US20080306077A1 (en)	2008-12-11
HRP20120909T1 (en)	2012-12-31
HRP20120909T4 (hr)	2013-11-08
TW200911254A (en)	2009-03-16
RU2470931C2 (ru)	2012-12-27

Publication	Publication Date	Title
HRP20150210T1 (en)	2015-06-05	Oxadiazole derivatives and their use as metabotropic glutamate receptor -842 potentiators
HK1155744A1 (en)	2012-05-25	Isoxazole derivatives and their use as metabotropic glutamate receptor potentiators
EP2167501A4 (en)	2011-03-30	OXADIAZOLE LIGANDS FROM METABOTROPIC GLUTAMATE RECEPTORS AND THEIR USE AS POTENTIALIZERS - 841
IL211042A0 (en)	2011-04-28	Imidazopyridin-2-one derivatives and uses thereof
IL210412A0 (en)	2011-03-31	Heterocyclic derivatives and uses thereof
ZA201103635B (en)	2012-10-31	Azaquinolinone derivatives and uses thereof
AP2011005613A0 (en)	2011-04-30	Heteroaryls amide derivatives and their use as glucokinase activators.
EP2200613A4 (en)	2010-10-27	PINEZIN DERIVATIVES AND USES THEREOF
ZA201104423B (en)	2012-03-28	Oxadiazole derivatives
HK1148686A1 (en)	2011-09-16	Vitamin e derivatives and their uses
IL205176A0 (en)	2010-11-30	Pyridazinone derivatives and use thereof as p2x7 receptor inhibitors
IL213168A0 (en)	2011-07-31	1,2,4-oxadiazole derivatives and their therapeutic use
EP2123644A4 (en)	2011-06-29	BENZOXAZEPINE DERIVATIVES AND THEIR USE
HRP20140047T1 (en)	2014-02-14	Cycloptopyl amide derivatives
IL208771A0 (en)	2010-12-30	Iminopyridine derivatives and use thereof
IL206951A0 (en)	2010-12-30	3-alkyl-piperazine derivatives and uses thereof
EP2274294A4 (en)	2011-08-10	5-DIMETHOXY FUMAGILLOL AND ITS DERIVATIVES
IL206950A0 (en)	2010-12-30	Aminopiperidinyl derivatives and uses thereof
IL200457A0 (en)	2010-04-29	Isoflavone derivatives and uses thereof
IL196823A0 (en)	2009-11-18	Tetraarylporphine derivatives and uses thereof
IL204617A0 (en)	2010-11-30	N-phenyl anthranilic acid derivatives and uses thereof
GB0711398D0 (en)	2007-07-25	Substituted organpolysiloxanes and uses thereof